Indian Council of Medical Research consensus document for the management of gastroenteropancreatic neuroendocrine neoplasms

Indian Council of Medical Research consensus document for the management of gastroenteropancreatic neuroendocrine neoplasms

Saved in:

Bibliographic Details
Main Authors:	Bhawna Sirohi, Savio G Barreto, Shailesh V Shrikhande, Manish Bhandare, Munita Bal, Raju T Chacko, Vikram Bhatia, Sandip Basu, Sanjay Thulkar, Tanvir Kaur, R S Dhaliwal, Goura Kishor Rath
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:	Indian Journal of Medical and Paediatric Oncology
Online Access:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=2;spage=166;epage=172;aulast=
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indian council of medical research consensus document for the management of pancreatic cancer
by: Shailesh V Shrikhande, et al.
Published: (2019-01-01)

Peptide receptor radionuclide therapy in the management of neuroendocrine tumors (Neoplasms)*: Fundamentals and salient clinical practice points for medical oncologists
by: Sandip Basu, et al.
Published: (2019-01-01)

Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms
by: Johannes Uhlig, et al.
Published: (2024-12-01)

Classification of Gastroenteropancreatic Neuroendocrine Tumors
by: Paulina Vladova
Published: (2022-11-01)

Gastroenteropancreatic neuroendocrine tumors in children and adolescents
by: Ülkü Miray Yıldırım, et al.
Published: (2024-07-01)

Indian Council of Medical Research consensus document for the management of gastrointestinal stromal tumors
by: Shailesh V Shrikhande, et al.
Published: (2014-01-01)

Indian Council of Medical Research consensus document for the management of gastric cancer
by: Shailesh V Shrikhande, et al.
Published: (2014-01-01)

Indian Council of Medical Research consensus document for the management of colorectal cancer
by: Bhawna Sirohi, et al.
Published: (2014-01-01)

Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms
by: Na Li, et al.
Published: (2024-10-01)

Role of Bispecific Antibodies in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): Review of Literature
by: Amr Mohamed, et al.
Published: (2024-12-01)

Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms
by: Xuan-Peng Zhou, et al.
Published: (2025-03-01)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
by: Paweł Gut
Published: (2020-01-01)

Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms.
by: Suguru Miyazawa, et al.
Published: (2025-01-01)

Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms
by: Suguru Miyazawa, et al.
Published: (2025-01-01)

Exploring the expression of DLL3 in gastroenteropancreatic neuroendocrine neoplasms and its potential diagnostic value
by: L. Yin, et al.
Published: (2025-01-01)

MODERN PATHOLOGICAL CONSTELLATION FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS AND IMMUNOHISTOCHEMICAL PANEL
by: P. Vladova
Published: (2022-12-01)

Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms
by: Colin H. Quinn, et al.
Published: (2025-04-01)

Gastroenteropancreatic neuroendocrine tumor of the accessory papilla of the duodenum: a case report
by: Kosei Takagi, et al.
Published: (2021-06-01)

Clinicopathological study of 100 cases of neuroendocrine neoplasms of the gastroenteropancreatic system: A tertiary cancer center experience
by: Satarupa Tarak Nath Samanta, et al.
Published: (2020-01-01)

Prognostic value of neutrophil-lymphocyte ratio in gastroenteropancreatic neuroendocrine neoplasm: a systematic review and meta-analysis
by: Yajie Wang, et al.
Published: (2025-04-01)

Clinical trials in India: At uncertain crossroads?
by: Bhawna Sirohi, et al.
Published: (2014-01-01)

Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases
by: John F. Tierney, et al.
Published: (2019-01-01)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
by: Beata Kos-Kudła, et al.
Published: (2017-06-01)

Machine learning predicts prognosis in patients with gastroenteropancreatic neuroendocrine tumors with liver metastases
by: Fuli Gao, et al.
Published: (2025-05-01)

Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features
by: Nuerailaguli Jumai, et al.
Published: (2025-07-01)

Management of liver metastases from non-functional gastroenteropancreatic neuroendocrine tumors: a systematic review
by: Jun-shuai Xue, et al.
Published: (2025-07-01)

Global research trends in gastroenteropancreatic neuroendocrine tumors: a bibliometric analysis from 2000 to 2023
by: Lei Wu, et al.
Published: (2025-05-01)

Current insights and future directions in systemic therapies for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) in children and adolescents: a critical review of advancements and challenges
by: Michaela Kuhlen, et al.
Published: (2025-12-01)

Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?
by: Francesco Panzuto, et al.
Published: (2025-08-01)

Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
by: Felix L. Herr, et al.
Published: (2025-08-01)

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
by: Bhawna Sirohi, et al.
Published: (2016-01-01)

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan
by: Jen-Shi Chen, et al.
Published: (2024-08-01)

Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol
by: Suzanne Polinder, et al.
Published: (2025-07-01)

The clinical benefits of [18F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [18F]FDG PET/CT
by: Donghe Chen, et al.
Published: (2025-07-01)

Gastrointestinal stromal tumor – An overview
by: Anant Ramaswamy, et al.
Published: (2020-01-01)

National cancer control and registration program in India
by: Goura Kishor Rath, et al.
Published: (2014-01-01)

Impact of Interventional Radiology in Modern-Day Pancreatic Surgery
by: Suyash Kulkarni, et al.
Published: (2025-08-01)

Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
by: Bhawna Sirohi, et al.
Published: (2014-01-01)

Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (18F-fluorodeoxyglucose and 68Ga-DOTATATE) correlates and their treatment implications
by: Sarvesh Loharkar, et al.
Published: (2021-03-01)

Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience: Retraction
by: Bhawna Sirohi
Published: (2015-01-01)